
Dr. George Zhanel discusses the latest developments in antimicrobial stewardship with a focus on IV Amox Clav.
In this episode, made possible through an educational grant from Sandoz Canada , Dr. George Zhanel discusses the latest developments in antimicrobial stewardship, focusing on IV Amox Clav, its clinical applications, safety profile, and the Canadian Leadership on Antimicrobial Real-Life Usage Registry (CLEAR). Gain insights into optimizing antibiotic use and future prospects in antimicrobial development. Key Topics: IV Amox Clav clinical applications Canadian Leadership on Antimicrobial Usage Registry (CLEAR) Antibiotic stewardship strategies Future developments in antimicrobial agents Chapters: 00:00 Introduction and Guest Credibility 01:47 Introduction of Dr. George Zhanel and his background 02:41 The journey into IV Amox Clav and its significance 03:21 Overview of the CLEAR registry and its purpose 06:18 Findings from the CLEAR study on IV Amox Clav usage 07:57 Clinical indications and safety profile of IV Amox Clav 10:58 De-escalation and appropriate use of IV Amox Clav 12:34 Use in bacteremia and various infections 13:35 Side effects and safety data of IV Amox Clav 15:02 Dosing strategies and renal adjustments 17:29 Beta-lactamase inhibitors and future antimicrobial…
Sandoz Canada
Explore listener stats, chart rankings, contacts and more on the The Critical Care Commute Podcast podcast page.